Related references
Note: Only part of the references are listed.Molecular interaction of anti-cancer ligands with human brain acetylcholinesterase
Shazi Shakil
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression
Maria-Angeles Cortes-Gomez et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Extracellular ATP Mediates Cancer Cell Migration and Invasion Through Increased Expression of Cyclooxygenase 2
Shilpa Sharma et al.
FRONTIERS IN PHARMACOLOGY (2021)
New Amidated 3,6-Diphenylated Imidazopyridazines with Potent Antiplasmodium Activity Are Dual Inhibitors of Plasmodium Phosphatidylinositol-4-kinase and cGMP-Dependent Protein Kinase
Peter Mubanga Cheuka et al.
ACS INFECTIOUS DISEASES (2021)
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells
Monika Hudacova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of organophosphorous pesticides and acetylcholine in breast carcinogenesis
Gloria M. Calaf
SEMINARS IN CANCER BIOLOGY (2021)
Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities
Yuichi Sawaguchi et al.
FRONTIERS IN PHARMACOLOGY (2021)
Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors
Hong Bu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential
Igor A. Schepetkin et al.
BIOMOLECULES (2021)
Design and synthesis of Imidazo[1,2-b]pyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma
Yun Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease
Silvia Chaves et al.
MOLECULES (2020)
MicroRNA miR-212 regulates PDCD4 to attenuate Aβ25-35-induced neurotoxicity via PI3K/AKT signaling pathway in Alzheimer's disease
Yanjun Wang et al.
BIOTECHNOLOGY LETTERS (2020)
IGFBP-3 Blocks Hyaluronan-CD44 Signaling, Leading to Increased Acetylcholinesterase Levels in A549 Cell Media and Apoptosis in a p53-Dependent Manner
Deanna Price et al.
SCIENTIFIC REPORTS (2020)
Green Tea Seed Isolated Theasaponin E1 Ameliorates AD Promoting Neurotoxic Pathogenesis by Attenuating Aβ Peptide Levels in SweAPP N2a Cells
Muhammad Imran Khan et al.
MOLECULES (2020)
Probing simple structural modification of α-mangostin on its cholinesterase inhibition and cytotoxicity
Kooi-Yeong Khaw et al.
ARCHIV DER PHARMAZIE (2020)
New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation
Atamjit Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation
Paulo L. Pfitzinger et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation
Jonathan Elie et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Discovery of 2-(Imidazo[1,2-b]pyridazin-2-yl)acetic Acid as a New Class of Ligands Selective for the γ-Hydroxybutyric Acid (GHB) High-Affinity Binding Sites
Jacob Krall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Binding to an Unusual Inactive Kinase Conformation by Highly Selective Inhibitors of Inositol-Requiring Enzyme 1α Kinase-Endoribonuclease
Giampiero Colombano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Acetylcholine signaling system in progression of lung cancers
Jamie R. Friedman et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors
Chunjian Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors
Makoto Fushimi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells
Yuhong Jiang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Cholinesterases and the fine line between poison and remedy
Carey N. Pope et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Structure-based design, synthesis, and biological evaluation of imidazo [1,2-b]pyridazine-based p38 MAP kinase inhibitors
Akira Kaieda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Imidazo[2′,1′:2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study
Menna A. Ewida et al.
BIOORGANIC CHEMISTRY (2018)
Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis
Esperance Moine et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2018)
Dioxin induces expression of hsa-miR-146b-5p in human neuroblastoma cells
Tuan Xu et al.
JOURNAL OF ENVIRONMENTAL SCIENCES (2018)
Antiplasmodial imidazopyridazines: structure-activity relationship studies lead to the identification of analogues with improved solubility and hERG profiles
Peter Mubanga Cheuka et al.
MEDCHEMCOMM (2018)
Design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine derivatives as mTOR inhibitors
Beibei Mao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015)
Stanton F. McHardy et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines
Rakesh Kumar Sharma et al.
NEUROTOXICITY RESEARCH (2017)
Anti-Metastatic Effect of Dehydrocorydaline on H1299 Non-Small Cell Lung Carcinoma Cells via Inhibition of Matrix Metalloproteinases and B Cell Lymphoma 2
Jihyun Lee et al.
PHYTOTHERAPY RESEARCH (2017)
Neuronal Mitophagy in Neurodegenerative Diseases
Marta Martinez-Vicente
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Drugs Against Neurodegenerative Diseases: Design and Synthesis of 6-Amino-substituted Imidazo[1,2-b]pyridazines as Acetylcholinesterase Inhibitors
P. Sridhar et al.
CHEMISTRYSELECT (2017)
Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs
Tamara Lazarevic-Pasti et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Jianping Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development
Judith L. Green et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Coumarins as cholinesterase inhibitors: A review
Luana G. de Souza et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Old and new acetylcholinesterase inhibitors for Alzheimer's disease
Daniela Galimberti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Acetylcholinesterase is associated with a decrease in cell proliferation of hepatocellular carcinoma cells
Benjamin Perez-Aguilar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity
Ken-ichi Kusakabe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-IRK Inhibitors
Ha-Soon Choi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Hsp27 suppresses the Cu2+-induced amyloidogenicity, redox activity and cytotoxicity of α-synuclein by metal ion stripping
Abhishek Asthana et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
Miroslav Pohanka
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain
Bernd L. Fiebich et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor
Naoki Miyamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Shared and Cell Type-Specific Mitochondria! Defects and Metabolic Adaptations in Primary Cells from PINK1-Deficient Mice
Ravi S. Akundi et al.
NEURODEGENERATIVE DISEASES (2013)
Was Phenserine a Failure or Were Investigators Mislead by Methods?
Robert E. Becker et al.
Current Alzheimer Research (2012)
siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells
Ramesh J. L. Kandimalla et al.
JOURNAL OF BIOMEDICAL SCIENCE (2012)
Stable knockdown of MYCN by lentivirus-based RNAi inhibits human neuroblastoma cells growth in vitro and in vivo
Richeng Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 3: Exploration of effective compounds in arthritis models
Hiroki Shimizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
Lisa S. Chen et al.
BLOOD (2011)
Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells
Qianqian Li et al.
EXPERIMENTAL GERONTOLOGY (2010)
Phenserine Efficacy in Alzheimer's Disease
Bengt Winblad et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Neural mechanisms of ageing and cognitive decline
Nicholas A. Bishop et al.
NATURE (2010)
α3*and α7 nAChR-mediated Ca2+ transient generation in IMR-32 neuroblastoma cells
Hilde Ween et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect
Enza Palazzo et al.
NEUROPHARMACOLOGY (2010)
Muscarinic receptors and ligands in cancer
Nirish Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation
Prodyot K. Chatterjee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin
Maria Grazia Rimoli et al.
NEUROPHARMACOLOGY (2009)
Hypoxia Alters Cell Cycle Regulatory Protein Expression and Induces Premature Maturation of Oligodendrocyte Precursor Cells
Ravi Shankar Akundi et al.
PLOS ONE (2009)
Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia
Jean-Pierre Raufman et al.
CANCER RESEARCH (2008)
Acetylcholinesterase supports anchorage independence in colon cancer
Moyeenuddin Syed et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer
Daniel W. Visscher et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer
F. Gregory Buchanan et al.
CANCER RESEARCH (2007)
Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance
Tomoyuki Iwasaki et al.
INTERNAL MEDICINE (2007)
Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: The Hisayama study
Kouhei Fujimi et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis
R. Deng et al.
ONCOGENE (2006)
Forskolin, an inducer of cAMP, up-regulates acetylcholinesterase expression and protects against organophosphate exposure in neuro 2A cells
Bryan F. Curtin et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Eosinophil-mediated cholinergic nerve remodeling
Niamh Durcan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Analysis of apoptosis by propidium iodide staining and flow cytometry
Carlo Riccardi et al.
NATURE PROTOCOLS (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Expression of cholinesterases in brain and non-brain tumours
CJ Vidal
CHEMICO-BIOLOGICAL INTERACTIONS (2005)
Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors
Q Shen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia
RS Akundi et al.
GLIA (2005)
1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH
RS Akundi et al.
JOURNAL OF NEUROCHEMISTRY (2004)
The AMP-activated protein kinase pathway - new players upstream and downstream
DG Hardie
JOURNAL OF CELL SCIENCE (2004)
3-(4-{[benzyl(methyl)amino]methyl}-phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation:: A dual function lead for Alzheimer's disease therapy
L Piazzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells
K Lieb et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
Complex regulation of acetylcholinesterase gene expression in human brain tumors
C Perry et al.
ONCOGENE (2002)
Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents
J Kassa
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2002)
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
RA Gupta et al.
NATURE REVIEWS CANCER (2001)
Sensitive determination of cell number using the CyQUANT® cell proliferation assay
LJ Jones et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors
M Barbosa et al.
SURGICAL NEUROLOGY (2001)